U.S. approves gene therapy treatment for hemophilia

26 avril 2024 | Agence France-Presse
Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
 Site référencé:  Raw Story

Raw Story 

Steve Bannon : Alito's wife now on 'shortlist' for Trump's VP
30/05/2024
Judge Merchan 'absolutely has the defense team sweating' during new jury instructions : CNN
30/05/2024
U.S. Democrats call for criminal probe into Big Oil price-fixing
30/05/2024
TV producers cobbled together footage to make 'overwhelmed' Trump 'sound sharp'
30/05/2024
Trump : New York will lose 'trillions and trillions' if you convict me
30/05/2024
GOP laser-focused on unraveling health care if Trump returns to power : sources
30/05/2024